Valneva SE is a specialty vaccine company focused on developing and commercializing innovative vaccines for infectious diseases

The company is committed to addressing significant unmet medical needs through its diverse pipeline of vaccine candidates, which includes programs for diseases such as Lyme disease and chikungunya. Valneva employs advanced technologies and extensive research to create safe and effective vaccines that aim to improve public health outcomes globally. By collaborating with various health organizations and leveraging its expertise in vaccine development, Valneva seeks to contribute to the prevention of infectious diseases and foster better health through vaccination.